Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial.

Bath PM, Woodhouse LJ, Appleton JP, Beridze M, Christensen H, Dineen RA, Duley L, England TJ, Flaherty K, Havard D, Heptinstall S, James M, Krishnan K, Markus HS, Montgomery AA, Pocock SJ, Randall M, Ranta A, Robinson TG, Scutt P, Venables GS, Sprigg N, TARDIS Investigators

Open source

DOI: 10.1016/s0140-6736(17)32849-0
Published: 2018 Mar 3
Container: Lancet (London, England)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-17-32849-0,
  title = {Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial.},
  author = {Bath PM and Woodhouse LJ and Appleton JP and Beridze M and Christensen H and Dineen RA and Duley L and England TJ and Flaherty K and Havard D and Heptinstall S and James M and Krishnan K and Markus HS and Montgomery AA and Pocock SJ and Randall M and Ranta A and Robinson TG and Scutt P and Venables GS and Sprigg N and TARDIS Investigators},
  year = {2018},
  journal = {Lancet (London, England)},
  doi = {10.1016/s0140-6736(17)32849-0},
  url = {https://doi.org/10.1016/s0140-6736(17)32849-0}
}

RIS

TY  - JOUR
TI  - Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial.
AU  - Bath PM
AU  - Woodhouse LJ
AU  - Appleton JP
AU  - Beridze M
AU  - Christensen H
AU  - Dineen RA
AU  - Duley L
AU  - England TJ
AU  - Flaherty K
AU  - Havard D
AU  - Heptinstall S
AU  - James M
AU  - Krishnan K
AU  - Markus HS
AU  - Montgomery AA
AU  - Pocock SJ
AU  - Randall M
AU  - Ranta A
AU  - Robinson TG
AU  - Scutt P
AU  - Venables GS
AU  - Sprigg N
AU  - TARDIS Investigators
PY  - 2018
JO  - Lancet (London, England)
DO  - 10.1016/s0140-6736(17)32849-0
UR  - https://doi.org/10.1016/s0140-6736(17)32849-0
ER  -

APA

PM, B., LJ, W., JP, A., M, B., H, C., RA, D., L, D., TJ, E., K, F., D, H., S, H., M, J., K, K., HS, M., AA, M., SJ, P., M, R., A, R., TG, R., P, S., GS, V., N, S., & Investigators, T. (2018). Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(17)32849-0

Source records

pubmed · retrieved 2026-09-27T14:03:23.776Z